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ABSTRACT 
Little is known about the behavioural effect of either Zinc or Linoleic acid or their combination in the delay of onset of 
Parkinson’s disease. This study was designed to investigate the effects of Zinc and Linoleic acid in the protection of behavioural 
deficits in rotenone-induced Parkinsonism in rats. Thirty six young adult female rats weighing 100-150 grams divided into six 
groups were used. Rats were induced with Parkinsonism by subcutaneous administration of rotenone (Sigma-Aldrich, St. Louis, 
SA) (2.5mg/kg) once a day for seven consecutive days. Rats  received (Dimethyl sulfoxide) DMSO/Olive oil or rotenone 
dissolved in DMSO/Olive oil. Groups III and IV received Zinc (30mg/kg) or Linoleic acid (150µl/kg) while group V received a 
combination of both, two weeks prior to rotenone injection. Groups II and VI served as negative (rotenone group) and positive 
(Levodopa groups) controls respectively. Measurement and analysis of behavioural function in rats employed a battery of tests 
including Elevated Plus Maze (EPM), Open Field Test (OFT), Novel Scent and Block Tests. Rats receiving rotenone displayed 
bradykinesia and motor impairment in the OFT, anxiety, decrease in olfactory acuity and discrimination in EPM, and Novel 
Scent Test respectively. The significant increase in postural instability, impaired motor activity/coordination, increased anxiety 
and the decrease in rearing behaviour caused by rotenone induction was attenuated significantly by treatment with Zinc and 
Linoleic acid, but not their combination. These results suggest that Zinc possess significant behavioural activity while Linoleic 
acid improves certain aspects of sensory and motor function than their combination. 
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Parkinson’s Disease, is the second most common 
neurodegenerative disorder with an incidence 
of around 14 per 100,000 population worldwide 
(Blanckenberg et al, 2013) and roughly 50,000 new cases arise 
every year. Parkinsonism refers to a clinical syndrome 
characterized by a variable combination of rest 
tremor, bradykinesia or akinesia, rigidity, and postural 
instability (Elbaz et al.,  2016; Prema et al.,  2015). Other non-
motor symptoms include anxiety, depression, sleep alteration, 
gastrointestinal dysfunction and olfactory disturbances which 
are one of the first non-motor symptoms observed in PD  
patients (Tillerson et al., 2006). 
Current treatment of Parkinson’s disease (PD) is based on 
dopamine replacement therapy, but 
chronic administration may cause motor fluctuations and 
dyskinesias, increased free radical 
formation, and may not address most of the non-motor 
symptoms (Dotchin, Msuya, & Walker, 2007). Several agents 
have been investigated for the management of behavioural 
deficits in   Parkinson disease, yet none has been largely 
successful.  Zinc has been used in the management of 
diarrhoea (Abdullah et al., 2006), acute lower respiratory 
infections (Sazawal et al., 1998) and male infertility (El-
Tawil, 2003). Linoleic acid, a potential nutraceutical has been 
shown to remediate behavioural deficits resulting from stroke 
(Iso et al., 2002) and dementia (Sydenham, Dangour Alan, & 
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Lim, 2012), yet their protective effect against the development 
of behavioural deficits in PD has not been investigated. The 
choice of Zinc for its use in PD is motivated by significant low 
levels of Zinc in the cerebrospinal fluid (CSF) of PD patients 
in several studies (Frederickson, Koh, & Bush, 2005). This 
suggests that Zinc deficiency may accompany many cases of 
PD. Chronic Linoleic acid deficiency significantly decreases 
storage formation of vesicles that store dopamine (Dyall & 
Michael-Titus, 2008; Eckert, Lipka, & Muller, 2013). 
 Evidence suggests that Zinc increases synthesis of 
metallothionein, an antioxidant which plays an important role 
in protecting dopaminergic neurons from free radical damage 
and environmental neurotoxins (Lehto et al., 2013), it also 
stabilizes the cell membrane. Linoleic acid modulates 
dopaminergic, serotoninergic and cholinergic 
neurotransmission and the transcription of genes involved in 
inflammation, oxidative stress and neurotrophic support 
(Zimmer et al., 2000). Using the hypothesis that micronutrient 
and trace element deficiency is implicated in  mitochondrial 
dysfunction and oxidative injury underlie neurodegeneration 
in PD (Eckert et al., 2013; Joshi, Mittal, Shukla, & Srivastav, 
2012; Tõugu & Palumaa, 2012); the inclusion of metabolic 
modifiers may provide an alternative and an early intervention 
approach. In order to investigate this we used a toxin-induced 
model of Parkinson’s disease to assess the protective effect of 
Zinc and Linoleic acid against development of behavioural 
deficits in PD patients. These agents may provide a potential 
therapy aimed for use as pharmacologic interventions to 
protect against behavioural deficits in PD. 
 
MATERIALS AND METHODS 
 
Chemicals and drugs: Zinc dust, linoleic acid and rotenone 
were obtained from Sigma-Aldrich, St Louis, SA. 125 mg of 
rotenone was dissolved in 1ml of DMSO to prepare a 50X 
stock solution of rotenone in 100% DMSO. 40µl of the stock 
solution (125 mgs/ml) was then diluted in 1960 µl of olive oil. 
The solution was vortexed to create a stable emulsion of the 
DMSO containing rotenone and Olive oil. The solution was 
made fresh 2-3 times/week and stored in an amber septa vial 
protected from light and inverted several times before each 
injection to eliminate the possibility of settling. The solution 
was administered at a volume of 1 ml/kg and control animals 
received the vehicle only (Olive oil/DMSO) (Ojha et al., 
2015). All other chemicals and reagents were obtained from 
the Biochemistry and Physiology laboratories of the 
University of Yaounde 1 Cameroon and were of analytical 
grade. 
 
Animals: Female Wistar rats were used in the present study. 
Their weights ranged between 100 and 150 g. 
The rats were housed in cages under clean laboratory 
conditions at room temperature with reversed light and dark 
cycles. Water and food pellets were given ad 
libitum. All the experimental protocols were approved by the 
Institutional Animal Care and 
Ethics Committees of the University of Yaounde 1, Cameroon 
under the reference number N° 
2017/01/699/CE/CNERSH/SP.  
Experimental design: Thirty six young adult female rats aged 
8-12 weeks and weighing 100-150 gm  obtained from the 
animal house, of the Faculty of Medicine and Biomedical 
Sciences, University of Yaounde 1, Cameroon and acclimated 
at room temperature of 25 ± 1 ºC (Hawkins, 2002) were used 
(Gupta et al., 1986). Parkinsonism was induced using 2.5 
mg/kg dose of rotenone subcutaneously (Ojha, Javed, 
Azimullah, Khair, & Haque, 2015). Rotenone was 
administered at a volume of 1 ml/kg body weight.  
 A group distribution flowchart detailing the different 
treatments and route of administration used in the study is 
shown below..  
 






Dosage Duration  
(days) 
Route  
I  Olive 
oil/DMSO 
1 ml/kg 21 PO 
II Rotenone 2.5mg/kg 7 last days SC 
III Zinc dust + 
rotenone 
30 mg/Kg + 
2.5 mg/kg 
21 days + 7 
last days for 
rotenone 
PO + SC 
(rotenone) 
IV Linoleic acid 
+ rotenone 
150 ug/kg + 
2.5 mg/kg 
21 days + 7 
last days for 
rotenone 
SC 
V Zinc + 
linoleic acid 
+ rotenone 
30 mg/kg + 
150 ug/kg + 
2.5 mg/kg 
21 days + 7 
last days for 
rotenone 







Last 7 days PO + SC 
PO= oral; SC = subcutaaneous 
 
Behavioural assessment: Twenty four (24) hours after the 
last injection of rotenone, rats were screened for behavioural 
deficits. Behavioural function in rats was measured using a 
series of tests including; the elevated plus maze which 
assessed anxiety behaviour, open field test assessed 
exploration and locomotor 
ability as well as anxiety. The novel scent and block tests 
assessed olfactory acuity and olfactory 
discrimination. Data collection instruments included a stop 
watch timer, video recorder, cages, and vanilla syrup, small 
blocks, elevated plus maze and wooden open field box. The 
rats were coded and behavioural assessment done by an 
independent trained experimenter blinded to groupings and 
interventions.  
 
Locomotor Assessment: The Open Field Test provides a 
means for measuring, exploration, locomotion and anxiety in 
rodents. The dimensions of the open field maze were 72 x 72 
cm with 36 cm walls. The large 
open field was used for measuring exploration as well as 
locomotion (Walsh & Cummins, 1976). Rats were placed into 
the centre or at the corners and were allowed to explore the 
space for minutes. The ambulation and rearing frequencies 
were used as measures of locomotor activity, but also 
measures of exploration and anxiety (Carola, D’Olimpio, 
Brunamonti, Mangia, & Renzi, 2002; Gould, Dao, & 
Kovacsics, 2009). Grooming and freezing were used as 
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measures of exploration and anxiety. The horizontal 
movement (ambulation frequency and freezing) and the 
vertical movement (rearing frequency) were registered 
(Stanford, 2007). 
 
Anxiety Assessment: Anxiety assessment was done using the 
elevated plus maze (Hogg, 1996). The time spent in the open 
and closed arms are assessed by this test and are used as 
measures of anxiety. Behaviour in this task reflects a conflict 
between the rodent’s preference for protected areas and their 
innate motivation to explore novel environments. The 
elevated plus maze relies upon rat’s inclination toward dark, 
enclosed spaces and a natural fear of heights and open spaces 
(Carola et al., 2002; Hogg, 1996; Holmes, Parmigiani, Ferrari, 
Palanza, & Rodgers, 2000). The EPM consisted of two open 
arms without walls and two arms closed by walls about 30cm 
high. The arms were 50 cm long and 10 cm wide. Each rat was 
placed at the junction of the four arms and number of entries 
and the total duration of entries into each arm were recorded 
for 5 minutes. The maze was cleaned with 70% alcohol and 
dried. The behavioural parameters recorded were: numbers of 
entries into the open and closed arms; time spent in the open 
and closed arms. Open arm time was used as an index of 
anxiety-like behaviour, while number of entries in closed arms 
was considered as a measure of locomotor activity (Pellow, 
Chopin, File, & Briley, 1985). A rat was considered to have 
entered an arm when all its four paws were on that arm. 
 
Assessment of olfactory acuity: Disturbances in sense of 
olfaction are one of the earliest non-motor symptoms observed 
in PD and patients. These include deficits in odour detection, 
differentiation, and identification (Tillerson et al., 2006). 
Olfactory acuity was measured using the novel scent test, 
which is a simple way of quantifying time spent sniffing a new 
odour (Doty, 2012; Doty, Shaman, Kimmelman, & Dann, 
1984). Each rat was presented small quantities of both vanilla 
and water simultaneously (Taylor et al., 2009). Time spent 
sniffing each odour was recorded for a three minute session. 
Time spent sniffing the vanilla indicates functional olfactory 
system to detect new odours. The frequency of sniffing 
indicates exploratory ability to novelty. 
 
Assessment of olfactory discrimination: The block test was 
used to evaluate the ability of rats to discriminate between 
social odours, specifically self and non-self (Taylor et al., 
2009). Each rat was presented with a block smeared with its 
own faecal matter and a block smeared with faecal matter of 
another rat of the same sex. The time spent in contact with 
each block was recorded for a two minute trial. More time 
spent sniffing the bedding of another rat indicated social 
attraction, cohesion and novelty, all of which points to the rat’s 
ability to discriminate between self from non-self as well as 
social groups. This ability is crucial for feeding, social 
communication and mating. It is also crucial for the process of 
learning and memory that come along with these behaviours. 
 
Statistical analysis: Results were collected, tabulated and 
expressed as mean ± S.E.M. Measurements were analyzed 
using one-way analysis of variance, ANOVA, followed by 
Tukey's multiple comparisons test. All statistical tests were 
done employing Graph Pad Prism version 6. Differences were 




Administration of rotenone (2.5 mg/kg) subcutaneously for 
seven days consecutively produced anxiety-like behaviors in 
the elevated plus maze, bradykinesia and postural instability 
in the open field test.  
 
Assessment of behavioural function: Treatment with Zinc, 
Linoleic acid or their combination ameliorated to varying 
degrees the behavioural deficits due to administration of 
rotenone. 
 
Locomotor Assessment: There was a significant decrease in 
the locomotor activity, as expressed by decreased ambulation 
frequency and rearing, in case of rotenone group when 
compared with control group (P < 0.05)  
 
Latency of movement initiation: Rotenone-treated rats 
showed increased latency to initiate movement as compared 
to the control rats (p<0.05). Zinc, Linoleic acid and their 
combination reduced the latency time as compared to 
rotenone-treated group (p<0.05). The effect of Linoleic acid 
was also significantly higher when compared to vehicle group 

















































































Figure 1:  
Effect of Zinc, Linoleic acid and their combination on the latency for 
initiation of movement by rats.  




The present results showed a significant reduction in 
frequency of ambulation in rotenone group 
as compared to the normal control group (Fig. 2). Zinc, 
significantly increased the ambulation 
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frequency as compared to rotenone group (p<0.0001). Neither 
Linoleic acid nor the combination 
of Zinc and Linoleic acid significantly increased the 
ambulation frequency compared to the 







































































Figure 2:  
Effect of Zinc, Linoleic acid and their combination on the ambulation 
frequency of rats.  
*, p≤0.0001 compared to vehicle group, b p≤0.05 compared to 
Levodopa 
 
Freezing Duration: The duration of inactivity recorded as the 
freezing was significantly higher in rotenone-treated 
animals compared to the control group. Treatment with Zinc 
and Linoleic acid and their combination significantly reduced 
the freezing duration in comparison to the rotenone group 
(p≤0.0001, Table 2 and Figure 3) 
 
Grooming Duration: Rotenone-treated rats showed 
increased grooming duration as compared to the normal 
control group. Zinc and their combination but not Linoleic 
acid alone significantly decreased the 
grooming duration as compared to rotenone group (p≤0.0001 
and p<0.05 respectively, Table 2 and figure 4). 
 
Rearing frequency: The rotenone group showed significantly 
lower frequencies in rearing compared to the vehicle 
group (p<0.0001) (Table 2 and figure 5). In addition, the 
current results indicated that Zinc and 
Linoleic alone but not their combination significantly 
increased the rearing frequency compared to rotenone group 
(p≤0.0001 and p<0.05 respectively). The effect of Zinc 
(p<0.0001) and Linoleic acid (p<0.05) on the rearing behavior 
















































































Figure 4:  
Effect of Zinc, Linoleic acid and their combination on the grooming 
duration of rats. 






























































Figure 5:  
Effect of Zinc, Linoleic acid and their combination on rearing 
frequency of rats. 
*, p≤0.0001 compared to rotenone group; b<0.05 compared to 
rotenone group 
 
Anxiety Assessment: In the elevated plus maze, the rotenone-
treated group significantly spent less time in the open 
arm compared to the vehicle-treated group (p<0.05, Table 2). 
Zinc but not Linoleic acid or their combination significantly 
increased the number of entries into the open arms of the 
maze. compared to the rotenone-treated group (p < 0.0001). 
Zinc and its combination with Linoleic acid but not Linoleic 
acid alone significantly decreased the number of entries into 
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the close arms of the maze compared to the rotenone-treated 
group (p < 0.05). Zinc and Linoleic acid but not their 
combination increased the rearing frequency. 
 
Assessment of Olfactory acuity 
Rotenone-treated rats showed decreased sniffing time as 
compared to the vehicle-treated rats. Zinc and Linoleic acid 
and their combination significantly increased the sniffing 
duration of vanilla as compared to rotenone group (p≤0.0001 
Table 3). The sniffing of water by the 
rotenone-treated group was significant decreased (p< 0.05, 
Table 3) as compared to the vehicle-treated group. The 
frequency of sniffing vanilla was also significant decreased in 
the Zinc, Linoleic acid and the combination group when 
compared with the rotenone group. 
 
Assessment of Olfactory Discrimination 
Rotenone-treated rats showed significant decreased sniffing 
time of non-self-bedding as compared to the vehicle-treated 
rats (p<0.0001). Zinc and Linoleic acid and their combination 
significantly increased the sniffing duration of non-self 
bedding as compared to rotenone group 
(p≤0.0001 Table 4). In addition, Zinc and Linoleic acid and 
their combination significantly increased the frequency of 
sniffing non-self-bedding as compared to rotenone group 
(p≤0.0001 Table 4). 
 
Table 2:  
Effect of Zinc and Linoleic acid and their combination on parameters of elevated plus maze 
 Groups Open Arm Time (seconds) Close Arm Time (seconds) Open Arm Entries Close Arm Entries 
Vehicle 52.40 ± 9.626 129.2 ± 27.52 4.000 ± 0.5477 4.800 ±1.158 
Rotenone  15.00 ± 2.775 239.6 ± 21.45a 1.800±0.3742a 3.200 ± 0.6633 
Zinc 180.6 ± 18.50* 42.60± 2.502* 7.200±0.3742* 5.600 ± 0.2449 
Linoleic Acid  32.00 ± 4.680 186.4±17.69 3.400 ± 0.5099 6.000 ± 1.095 
Zinc + Linoleic Acid 56.60 ± 17.44* 117.6± 32.11* 3.000 ± 0.7071 3.600 ± 0.6782 
Levodopa 50.20 ± 8.558* 57.80± 7.566* 4.200± 0.3742b 5.200 ± 0.7348 
Results are expressed as mean ± SEM. a, p≤0.05 compared to vehicle group; b, p≤0.05 compared to rotenone group; * p≤0.0001 compared to 
rotenone group 
 
Table 3:  
Effect of Zinc and Linoleic acid and their combination on parameters of novel scent test 
 Groups Duration of sniffing water 
(seconds) 
Duration of sniffing vanilla 
(seconds)  
Freq. of sniffing 
water 
Freq. of sniffing 
vanilla 
Vehicle 25.00 ±3.536 93.20 ±4.576 2.000± 0.3162 4.200 ±0.3742 
Rotenone 15.00 ±2.588a 7.600 ± 3.203c 3.600± 0.4000 0.8000 ±0.3742a 
Zinc 18.40 ±1.288 93.00 ±5.385* 1.800 ±0.3742 5.600 ±0.9274* 
Linoleic Acid  7.600± 1.536b 81.00 ±5.486* 1.800 ±0.3742 6.600 ±0.7483* 
Zinc + Linoleic Acid 9.200 ±2.458 94.00 ±7.190* 2.600 ±0.5099 7.000 ±1.049* 
Levodopa 11.00± 0.7071 72.00 ±4.626* 2.200 ±0.3742 5.800 ±0.7348 
Results are expressed as mean ± SEM. a, p≤0.05 compared to vehicle group, b, p≤0.05 compared to rotenone group; c p≤0.0001 compared to 
vehicle group * p≤0.0001 compared to rotenone group 
 
Table 4:  
Effect of Zinc and Linoleic acid and their combination on parameters 
of block test 


































































Results are expressed as mean ± SEM. a, p≤0.0001 compared to 
vehicle group; b, p≤0.05 compared to rotenone group; * p≤0.0001 




Zinc, linoleic acid and their combination were used in this 
study to evaluate their protective effect against development 
of behavioural deficits in rats with parkinsonism induced by 
rotenone. Precious studies showed that subcutaneous 
administration of rotenone for a week precipitates both motor 
and non-motor impairments (Testa et al, 2005) including 
difficulties in the locomotor activity, decreased rearing 
behaviour, decreased anxiety and olfactory disturbances. 
Interestingly, pre-treatment of rats with Zinc or Linoleic acid 
improved several behavioural parameters. These 
improvements correlated with the enhancement of antioxidant 
activity. 
 Rotenone an alkaloid used often as a pesticide inhibits 
complex I of the respiratory chain. It is used in animal studies 
to generate toxin-based rodent models of Parkinson’s disease 
as it increases oxidative stress (Sherer et al., 2007; Tanner, 
2011). Rotenone provides a valuable model for studying both 
mechanisms of oxidative stress and neuroprotection by 
antioxidant agents because of its mechanism of action 
involving oxidative stress (Perfeito et al, 2012).  
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 Neuropathologically, rotenone induces the degeneration 
of the nigrostriatal dopaminergic pathway which is one of the 
cardinal pathological markers of Parkinson’s disease (Tanner, 
2011; Testa et al., 2005). As shown in our study, at the 
behavioural level, rotenone precipitates behavioural 
alterations including both motor and several non-motor 
deficits (Inden et al., 2011). We have also shown in a previous 
study that rotenone induced oxidative stress and histological 
alterations in the midbrain (Mbiydzenyuy et al., 2018). These 
alterations have been shown to correlate with the extent of 
striatal lesions of the rotenone-treated rats (Mulcahy, Walsh, 
Paucard, Rea, & Dowd, 2011). 
 Motor performances in all our experimental groups were 
assessed using the Open Field Test (Stanford, 2007). 
Remarkably, pretreatment of rats with Zinc protected the 
animals from the behavioural effects of Rotenone. In fact, rats 
treated with Zinc showed a significant increase in the 
frequency of ambulation and the numbers on entries in the 
elevated plus maze. This enhancement of locomotor activity 
in the Zinc group could be due to the relatively higher dose of 
the Zinc (30mg/kg) used in our study corroborating the 
already observed dose-dependent effect of Zinc on 
locomotion as assessed by the EPM (A Partyka, Jastrzebska-
Wiesek, & Nowak, 2010). Regarding Linoleic acid, no 
significant effect on motor activity was observed. This result 
corroborates with the studies of Bourre et al. (1989) in which 
diet rich in alpha- linoleic acid improved radial maze learning 
performance without affecting motor activity. Rearing is an 
important item of the behavioural repertoire in rodents used to 
explore the environment (Fleming et al., 2004). In the open 
field test, rearing as a vertical movement is more sensitive to 
nigral dopaminergic degeneration relative to horizontal 
movements (Carola et al., 2002). Like its effect on locomotor 
activity, Zinc prevented the deterioration of the rearing 
behavior induced by rotenone treatment; similar to Zinc pre-
treatment, Linoleic acid protected the rearing behavior of rats 
against the impairment effect of rotenone treatment. In a study 
on the role of omega-3 fatty acid status on rat adaptation to 
chronic restraint stress, Linoleic acid-enriched diet was able 
to abolish the stress-induced reduction in locomotor activity 
and rearing in the open field test (Calon & Cole, 2007). Zinc 
has been implicated in the metabolism of Linoleic acid to its 
other metabolites such as DHA and then to prostaglandins 
leading to diminished availability of Linoleic acid to influence 
motor activity (Iso et al., 2002). 
 Zinc and Linoleic acid exhibited anxiolytic-like effects in 
rats, as they both increased the percentage of time spent on 
open arms and the number of entries into the open arms. 
Although Samardzic et al. (2013) reported an anxiogenic 
effect    of    Zinc    (30mg/kg),    the    anti-anxiety    effect of 
Zinc shown in our study is consistent with previous studies 
(Erreger & Traynelis, 2008; Wlaź et al., 2011). The route of 
administration could account for these conflicting results. The 
bioavailability of Zinc has been shown to be variable 
depending on the route of administration (Bray & Bettger, 
1990). Mechanistically, the anxiolytic effect of Zinc has been 
linked with the inhibition of glutamate NMDA/AMPA 
receptors and an increase BDNF gene expression in the 
hippocampus (Brocardo et al., 2007; Szewczyk et al., 2008). 
Moreover, the reported modulation of the serotonin 
neurotransmission by zinc could underlie its effect on anxiety- 
like behaviour (Anna Partyka et al., 2011; Samardzic et al., 
2013). Linoleic acid has been suggested to act as an anxiolytic 
agent by preventing cellular inflammation as well as 
improving the antioxidant capacity of cells (Dyall & Michael- 
Titus, 2008; Ross, 2009; Seki, Tani, & Arita, 2009). Omega 3 
PUFAs have been shown to prevent the development of 
stress- related disorders such as anxiety and depression by 
protecting glutaminergic neurotransmission in stress induced 
damage (Denis, Potier, Vancassel, Heberden, & Lavialle, 
2013). In a study to investigate the beneficial effect of fish oil 
on anxiety, depression and cognitive behavior in olfactory 
bulbectomised rats, Pudell and colleagues suggested that the 
anti-anxiety effect of omega-3 PUFAs could be due to its 
ability to increase serotonin levels in the brain (Pudell et al., 
2014). 
 Impaired odour detection, differentiation, and 
identification    has    been    correlated    positively     with an 
increased risk of developing PD, suggesting that behavioural     
testing     of     olfaction      can      facilitate  an earlier detection 
of the disease (Doty et al., 1984; Henderson, Lu, Wang, 
Cartwright, & Halliday, 2003). These changes are not 
responsive to dopaminergic therapies (Tillerson et al., 2006). 
The rotenone group showed significant decrease in sniffing 
and exploration times. Zinc and Linoleic acid significantly 
increased the frequency and  duration  of   sniffing the novel 
scent indicating that they improved the olfactory senses in 
comparison to the rotenone group in which this was highly 
impaired. Zinc is believed to play an important role in the 
regeneration of receptor cells not only on taste buds, but also 
on the olfactory epithelium (Slotnick, Sanguino, Husband, 
Marquino, & Silberberg, 2007). Therefore, Zinc deficiency is 
thought to produce olfactory disorder (Duncan-Lewis, 
Lukman, & Banks, 2011; Jafek, Linschoten, & Murrow, 
2004) although details of the mechanism by which it does so 
are still unclear. The mechanism by which Linoleic acid 
improves olfactory function is not also clear but has been 
linked to its ability  to  its  antioxidant  role   in   the   olfactory 
epithelium as well as neural development (Karr, Alexander, 
& Winningham, 2011).  
 The data obtained from biochemical and histological 
assessments in a previous study with the same experimental 
protocol also revealed that systemic administration of 
rotenone (2.5 mg/kg doses, s.c.) in rats for seven days 
produced increased midbrain lipid peroxidation and impaired 
antioxidant status, accompanied by histological changes. Pre- 
treatment with zinc, linoleic acid and their combination 
prevented the increase in MDA levels and decrease in brain 
antioxidant status induced by rotenone treatment. Histological 
changes such as cell death and reduction in neuron size 
induced by rotenone was also prevented by pre-treatment with 
zinc, linoleic acid and their combination (Mbiydzenyuy et al., 
2018). 
 In conclusion, results of the present study show that 
repeated systemic administration of rotenone (2.5 mg/kg 
doses, s.c.) in rats produced functional impairment in the form 
of  bradykinesia  in  the  open-field  test  and  anxiety-  related 
behaviors in the elevated plus maze. The study showed that 
Zinc significantly increased the locomotor and exploratory 
activity of rats compared to Linoleic acid and their 
Behavioral effects of Zinc and linoleic acid 
253 Afr. J. Biomed. Res. Vol. 23, No.2 (May) 2020   Mbiydzenyuy  et al 
combination against rotenone treatment as shown by the open 
field test. Zinc also showed significant anxiolytic effect 
compared to Linoleic acid or their combination. Zinc, Linoleic 
acid and their combination significantly improved olfactory 
acuity  and  discrimination  as  shown  by   the   duration   and 
sniffing of vanilla and non-self bedding in the novel scent and 
block tests respectively. Zinc and Linoleic acid show 
prospects of slowing the onset of behavioural deficits that 
occur early at the outset of Parkinson’s disease. However 
further studies are needed to explore the possible mechanisms 
involved in these behavioural effects 
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